Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: SvájcFázis nélkül

Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury (BoxSwitch)

A legfontosabb adatok

Ki végzi
Ecole Polytechnique Fédérale de Lausanne
Hol
Lausanne (Svájc)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
8 fő, tervezett
Kezdés
2023. aug. 30.
Várható befejezés
2027. aug. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Procedure/Surgery
A regiszteradat frissítve
2025. december 11.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a long-standing spinal cord injury from trauma who already have an implanted spinal stimulation system. They would swap it for the new ARC-IM Lumbar system.

Életkor
18 to 65 years
Nem
All sexes
A betegség stádiuma
Spinal cord injury graded AIS A, B, C or D, for at least 12 months. Injury level T10 or higher, with the lowest end of the spinal cord (conus) still working. Injury must be caused by trauma.
Korábbi kezelés
Must already have an implanted spinal array (Specify 5-6-5 or Go2 Lead) for leg movement, for example from the STIMO study (NCT02936453) or similar studies.

A részvétel fő kizáró okai

  • Heart attack or stroke in the past 6 months
  • An active implanted heart device such as a pacemaker or defibrillator
  • Needing MRI or diathermy (heat treatment)
  • An implanted baclofen or insulin pump
  • Pregnant or breastfeeding

A regiszter feltételei, szó szerint

Mind a 24 feltétel megnézéseKevesebb

Ki vehet részt

  • Implanted with a spinal array (Specify 5-6-5 or Go2 Lead) for lower limb mobility, as confirmed by imaging, videos, or neurophysiology recordings
  • Age 18-65
  • SCI graded as American Spinal Injury Association Impairment Scale (AIS) A, B, C \& D
  • SCI ≥ 12months
  • SCI lesion level T10 and above with preservation of conus function
  • SCI due to trauma
  • Stable medical, physical and psychological condition as considered by the investigators
  • Able to understand and interact with the study team in French or English
  • Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments
  • Must provide and sign the Informed Consent prior to any study-related procedures

Ki nem vehet részt

  • Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.)
  • Diseases and conditions that would increase the morbidity and mortality of spinal cord injury surgery
  • History of myocardial infarction or cerebrovascular event within the past 6 months
  • Limitation of walking function based on accompanying (CNS) disorders (systemic malignant disorders, cardiovascular disorders restricting physical training, peripheral nerve disorders)
  • Any active implanted cardiac device such as pacemaker or defibrillator
  • Other conditions that would make the subject unable to participate in testing in the judgement of the investigators
  • Clinically significant mental illness in the judgement of the investigators
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, or dementia of the participant
  • Any indication that would require diathermy
  • Any indication that would require MRI
  • Any anatomical limitations in the implantation area as judged by the investigators
  • Presence of indwelling baclofen or insulin pump
  • Enrolment of the investigator, his/her family members, employees, and other dependent persons
  • Women who are pregnant (pregnancy test obligatory for women of childbearing potential) or breastfeeding

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 65 év között vagy?

Helyszínek itt: Svájc

  • CHUVLausanne, SvájcContact: Jocelyne Dr Bloch, Prof. Dr.Résztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this pre-market clinical study is to assess the preliminary safety and efficacy of the ARC Therapy using the ARC-IM Lumbar System at supporting mobility in participants who have previously received a spinal array and an implantable pulse generator (IPG) either through the STIMO protocol (NCT02936453) or similar studies conducted abroad. They will be proposed to exchange their currently implanted system with components of the newly developed ARC-IM Lumbar system. The goal is to improve more effective lower-limb motor activities, while also simplifying the personal at-home use of the system. In addition, this study aims to evaluate the potential effect of ARC Therapy on muscle tone, bladder, bowel and sexual functions, and quality of life of the participants.

A teljes eredeti leírásKevesebb

Preliminary safety and efficacy will be assessed in both the short term and throughout the duration of the study (from the surgery to 36 months after the implantation of the ARC-IM Lumbar system).

A vizsgálat csoportja

  • Targeted Epidural Spinal StimulationA vizsgált kezelés

    Single arm study: the participants who have previously received a spinal array and an implantable pulse generator either through the STIMO study or similar studies conducted abroad will be proposed to exchange their currently implanted system with selected components from the ARC-IM Lumbar system. After the surgery, the participants will perform around 20 optimization sessions that may include rehabilitation to configure the neuromodulation system. Then the participants will use the ARC-IM Lumbar system independently during daily life activities until the end of the 36 months post-surgery. Assessments will be planned throughout the course of the study at the end of the optimization phase, after 12 and 24 months post-surgery and at the end of the study, with and/or stimulation.

    Kezelés: Procedure/Surgery

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT05942339: ki vehet részt
A regiszteradat frissítve
2025. december 11.